Activated Vitamin D Associated with Mortality Drop in Chronic Kidney Disease
For patients with moderate-to-severe chronic kidney disease and hyperparathyroidism, activated vitamin D appears to lower the risk of death over two years, an observational study found.
The 429 patients with stage 3 or 4 disease who took oral calcitriol had a 26% reduced risk of death (P=0.016) and a 20% reduced risk of death or long-term dialysis (P=0.038) compared with 989 patients who did not take oral calcitriol, Bryan Kestenbaum, M.D., of the University of Washington here, and colleagues reported online in the Journal of the American Society of Nephrology. The results will be published in the August print issue.
These data have great importance to generalists and nephrologists. These data support the hypothesis that the secondary hyperparathyroidism Is a major problem for these patients.




Paul Prescott
May 9th, 2008 / 6:45 pm
Uh huh. My wife is a FP NP, and i would see her RATHER THAN most FPs.
But she is the exception. She is GOOD. She takes care of her patients.
OTOH, I have seen a LOT of NPs, PAs, I would not take my dog to. But i can say the same for a lot of MDs.
Let’s face it. a DEGREE does NOT make you GOOD.